文献速递外周血管介入腹部CT

预测TIPS术后门静脉高压症状复发或死亡

Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.
PubMed 文献 · Eur Radiol · 2022-01-11

本研究纳入206例接受TIPS治疗的肝硬化门静脉高压患者,随机分为训练集(n=138)和验证集(n=68),评估围手术期变量对无病生存期(DFS)的预测价值。结果显示TIPS支架远端距肝腔静脉交汇处距离(TIPS-DEP)≥6 mm患者的中位DFS为24.5个月,短于TIPS-DEP<6 mm者的72.8个月(p=0.004)。由年龄≥60岁、Child-Pugh B或C级、TIPS-DEP≥6 mm构成的评分系统在训练集中可预测DFS,但验证集中风险比未达统计学显著。

要点

  • TIPS-DEP≥6 mm患者中位DFS为24.5个月,短于TIPS-DEP<6 mm者的72.8个月(p=0.004)。
  • TIPS-DEP<6 mm者标志点后6.5个月DFS概率为78%。
  • 由年龄≥60岁、Child-Pugh B或C级、TIPS-DEP≥6 mm各1分构成的评分系统可预测DFS。

核心结论

  • TIPS-DEP是可操作的影像生物标志物,可与年龄和Child-Pugh评分联合预测TIPS术后死亡或门静脉高压症状复发。

研究设计与样本

  • 研究纳入206例接受TIPS治疗的肝硬化门静脉高压患者,随机分为训练集(n=138)和验证集(n=68),记录7项流行病学、4项临床和9项影像学变量,TIPS-DEP在增强CT上测量支架远端与肝腔静脉交汇处的距离,训练集采用随机森林生存算法筛选变量并构建评分系统,主要终点为TIPS-DEP与DFS的关联,次要终点为在验证集中验证评分系统。

关键影像表现/征象

  • TIPS-DEP测量的是增强CT上支架远端与肝腔静脉交汇处之间的距离。
  • TIPS-DEP≥6 mm患者(n=49)中位DFS为24.5个月,TIPS-DEP<6 mm患者(n=157)中位DFS为72.8个月(p=0.004)。
  • 未满足年龄≥60岁、Child-Pugh B或C级、TIPS-DEP≥6 mm这三项标准的患者,标志点后6.5个月DFS概率分别为86%、80%和78%。

诊断标准与关键数值

  • TIPS-DEP≥6 mm为风险阈值,对应中位DFS 24.5个月,而TIPS-DEP<6 mm对应72.8个月(p=0.004)。
  • 评分系统:年龄≥60岁、Child-Pugh B或C级、TIPS-DEP≥6 mm各计1分。
  • 低危组(<2分)与高危组(≥2分)的风险比在训练集为2.30(95%CI 1.35-3.93,p=0.002),在验证集为2.01(95%CI 0.94-4.32,p=0.072)。
  • TIPS-DEP<6 mm者标志点后6.5个月DFS概率为78%。

临床应用与阅片要点

  • TIPS术后增强CT阅片时可测量支架远端与肝腔静脉交汇处的距离(TIPS-DEP),TIPS-DEP≥6 mm提示DFS较短。
  • 可结合年龄≥60岁、Child-Pugh B或C级及TIPS-DEP≥6 mm三项各1分计算评分,评分≥2分者为高危组。
  • 验证集中风险比95%CI跨1(p=0.072),未达统计学显著。

局限性

  • 验证集中低危组与高危组风险比为2.01(95%CI 0.94-4.32,p=0.072),未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Accurate prediction of portal hypertension recurrence after transjugular intrahepatic portosystemic shunt (TIPS) placement will improve clinical decision-making.

PURPOSE: To evaluate if perioperative variables could predict disease-free survival (DFS) in cirrhotic patients with portal hypertension (PHT) treated with TIPS.

MATERIALS AND METHODS: We recruited 206 cirrhotic patients with PHT treated with TIPS, randomly assigned to training (n = 138) and validation (n = 68) sets. We recorded 7 epidemiological, 4 clinical, and 9 radiological variables. TIPS-distal end positioning (TIPS-DEP) measured the distance between the distal end of the stent and the hepatocaval junction on contrast-enhanced CT scans. In the training set, the signature was defined as the random forest for survival algorithm achieving the lowest error rate for the prediction of DFS which was landmarked 4 weeks after the TIPS procedure. In the training set, a simple to use scoring system was derived from variables selected by the signature. The primary endpoint was to assess if TIPS-DEP was associated with DFS. The secondary endpoint was to validate the scoring system in the validation set.

RESULTS: Overall, patients with TIPS-DEP ≥ 6 mm (n = 49) had a median DFS of 24.5 months vs. 72.8 months otherwise (n = 157, p = 0.004). In the training set, the scoring system was calculated by adding age ≥ 60 years old, Child-Pugh B or C, and TIPS-DEP ≥ 6 mm (1 point each) since the signature showed high DFS probability at 6.5 months post-landmark in patients that did not meet these criteria: 86%, 80%, and 78%, respectively. The hazard ratio [95 CI] between patients determined to be low-risk (< 2 points) and high-risk (≥ 2 points) was 2.30 [1.35-3.93] (p = 0.002) in the training set and 2.01 [0.94-4.32] (p = 0.072) in the validation set.

CONCLUSION: TIPS-DEP is an actionable radiological biomarker which can be combined with age and Child-Pugh score to predict death or PHT symptom recurrence after TIPS procedure.

KEY POINTS: • TIPS-DEP measurement was the third most important but only actionable variable for predicting DFS. • TIPS-DEP < 6 mm was associated with a DFS probability of 78% at 6.5 months post-landmark. • A simple scoring system calculated using age, Child-Pugh score, and TIPS-DEP predicted DFS after TIPS.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Sun, Eche, Dorczynski, et al. Predicting death or recurrence of portal hypertension symptoms after TIPS procedures. Eur Radiol. 2022. PMID: 35015124. doi:10.1007/s00330-021-08437-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。